Viking Therapeutics Stock Price on December 23, 2024
| VKTX Stock | USD 42.35 0.03 0.07% |
Below is the normalized historical share price chart for Viking Therapeutics extending back to April 29, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Viking Therapeutics stands at 42.35, as last reported on the 27th of December, with the highest price reaching 42.91 and the lowest price hitting 41.61 during the day.
If you're considering investing in Viking Stock, it is important to understand the factors that can impact its price. Viking Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0996, which indicates the firm had a -0.0996% return per unit of risk over the last 3 months. Viking Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Viking Therapeutics' Coefficient Of Variation of (971.85), risk adjusted performance of (0.07), and Variance of 25.61 to confirm the risk estimate we provide.
Viking Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of April 2015 | 200 Day MA 61.4586 | 50 Day MA 56.8659 | Beta 0.994 |
Viking |
Sharpe Ratio = -0.0996
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VKTX |
Estimated Market Risk
| 5.17 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.51 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Viking Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Viking Therapeutics by adding Viking Therapeutics to a well-diversified portfolio.
Price Book 5.1778 | Book Value 8.179 | Enterprise Value 3.8 B | Enterprise Value Ebitda (71.64) | Shares Float 105.5 M |
Viking Therapeutics Main Headline on 23rd of December 2024
Hot Obesity Drug Market Will Keep Investors Gripped Next Yea... by bnnbloomberg.ca
Disappointing trial results for Novo Nordisk ASs experimental obesity shot capped a volatile year for investors in drug developers vying for a piece of pharmas hottest market.
Viking Therapeutics Valuation on December 23, 2024
It is possible to determine the worth of Viking Therapeutics on a given historical date. On December 23, 2024 Viking was worth 42.3 at the beginning of the trading date compared to the closed value of 42.32. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Viking Therapeutics stock. Still, in general, we apply an absolute valuation method to find Viking Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Viking Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Viking Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 44.18 | 45.00 | 41.98 | 42.25 | 8,822,062 | |
12/23/2024 | 42.30 | 42.67 | 40.77 | 42.32 | 2,939,529 |
| 42.32 | 42.91 | 41.61 | 42.35 | 1,059,667 |
| Backtest Viking Therapeutics | | | Viking Therapeutics History | | | Viking Therapeutics Valuation | Previous | Next |
Viking Therapeutics Trading Date Momentum on December 23, 2024
| On December 24 2024 Viking Therapeutics was traded for 42.35 at the closing time. The top price for the day was 42.91 and the lowest listed price was 41.61 . The trading volume for the day was 1.1 M. The trading history from December 24, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 0.07% . The trading price change against the current closing price is 0.00% . |
Viking Therapeutics Fundamentals Correlations and Trends
By evaluating Viking Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Viking Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Viking financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Viking Therapeutics Stock history
Viking Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Viking is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Viking Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Viking Therapeutics stock prices may prove useful in developing a viable investing in Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company was incorporated in 2012 and is headquartered in San Diego, California. Viking Thera operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.
Viking Therapeutics Quarterly Net Working Capital |
|
Viking Therapeutics Stock Technical Analysis
Viking Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Viking Therapeutics Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
Viking Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Viking Therapeutics December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Viking Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Viking Therapeutics shares will generate the highest return on investment. By undertsting and applying Viking Therapeutics stock market strength indicators, traders can identify Viking Therapeutics entry and exit signals to maximize returns
Viking Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Viking Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Viking Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Viking to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.07) | |||
| Jensen Alpha | (0.50) | |||
| Total Risk Alpha | (0.81) | |||
| Treynor Ratio | 0.6861 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Viking Stock Analysis
When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.